Skip to main content
SpringerLink
Log in

Long-Term Follow-Up of Retinoblastoma Survivors

  • Chapter
Recent Advances in Retinoblastoma Treatment

Part of the book series: Essentials in Ophthalmology ((ESSENTIALS))

  • 941 Accesses

Abstract

Over the past century, advances in the treatment of retinoblastoma have resulted in dramatically improved survival rates. As a result, increased attention has been given to the delineation, early identification, and treatment of survivors’ potential late effects of therapy, which may develop many years after initial treatment. While adverse oculo-visual outcomes and an increased risk of subsequent primary malignancies (in those with the genetic form of the disease) are well-documented, little is known about retinoblastoma survivors’ long-term general health and health status. The current chapter seeks to summarize the published data on retinoblastoma-specific late effects and highlight areas of inquiry which warrant further investigation. We begin by providing background on general childhood cancer survivorship and then survey the published literature on retinoblastoma-specific late medical outcomes, health-related quality of life, and cognitive outcomes. We also include data on extra-ocular retinoblastoma survivors’ late effect profiles as well as recent published data on the utility of whole body MRI screening in those with the genetic form of the disease. We conclude with clinical recommendations for the long-term care of retinoblastoma survivors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abramson DH, Frank CM. Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related risk. Ophthalmology. 1998;105(4):573–9. Discussion 579–580.

    Article  CAS  PubMed  Google Scholar 

  • Abramson DH, Melson MR, Dunkel IJ, Frank CM. Third (fourth and fifth) nonocular tumors in survivors of retinoblastoma. Ophthalmology. 2001;108(10):1868–76.

    Article  CAS  PubMed  Google Scholar 

  • Abramson DH, Melson MR, Servodidio C. Visual fields in retinoblastoma survivors. Arch Ophthalmol. 2004;122(9):1324–30.

    Article  PubMed  Google Scholar 

  • COG. Children’s Oncology Group long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers, version 4.0. 2014. Accessed 2 Oct 2014.

    Google Scholar 

  • DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, Alteri R, Robbins AS, Jemal A. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64(4):252–71.

    Article  PubMed  Google Scholar 

  • Desjardins L, Chefchaouni MC, Lumbroso L, Levy C, Asselain B, Bours D, Vedrenne J, Zucker JM, Doz F. Functional results after treatment of retinoblastoma. J AAPOS. 2002;6(2):108–11.

    Article  PubMed  Google Scholar 

  • Diller L, Chow EJ, Gurney JG, Hudson MM, Kadin-Lottick NS, Kawashima TI, Leisenring WM, Meacham LR, Mertens AC, Mulrooney DA, Oeffinger KC, Packer RJ, Robison LL, Sklar CA. Chronic disease in the Childhood Cancer Survivor Study cohort: a review of published findings. J Clin Oncol. 2009;27(14):2339–55.

    Article  PubMed Central  PubMed  Google Scholar 

  • Ek U, Seregard S, Jacobson L, Oskar K, Af Trampe E, Kock E. A prospective study of children treated for retinoblastoma: cognitive and visual outcomes in relation to treatment. Acta Ophthalmol Scand. 2002;80(3):294–9.

    Article  PubMed  Google Scholar 

  • Eldridge R, O’Meara K, Kitchin D. Superior intelligence in sighted retinoblastoma patients and their families. J Med Genet. 1972;9(3):331–5.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Eng C, Li FP, Abramson DH, Ellsworth RM, Wong FL, Goldman MB, Seddon J, Tarbell N, Boice Jr JD. Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst. 1993;85(14):1121–8.

    Article  CAS  PubMed  Google Scholar 

  • Francis JH, Kleinerman RA, Seddon JM, Abramson DH. Increased risk of secondary uterine leiomyosarcoma in hereditary retinoblastoma. Gynecol Oncol. 2012;124(2):254–9.

    Article  PubMed Central  PubMed  Google Scholar 

  • Friedman DN, Sklar CA, Oeffinger KC, Kernan NA, Khakoo Y, Marr BP, Wolden SL, Abramson DH, Dunkel IJ. Long-term medical outcomes in survivors of extra-ocular retinoblastoma: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience. Pediatr Blood Cancer. 2013;60(4):694–9.

    Article  PubMed  Google Scholar 

  • Friedman DN, Lis E, Sklar CA, Oeffinger KC, Reppucci M, Fleischut MH, Francis JH, Marr B, Abramson DH, Dunkel IJ. Whole-body magnetic resonance imaging (WB-MRI) as surveillance for subsequent malignancies in survivors of hereditary retinoblastoma: A pilot study. Pediatr Blood Cancer. 2014;61(8):1440–4.

    Article  PubMed Central  PubMed  Google Scholar 

  • Geenen MM, Cardous-Ubbink MC, Kremer LC, van den Bos C, van der Pal HJ, Heinen RC, Jaspers MW, Koning CC, Oldenburger F, Langeveld NE, Hart AA, Bakker PJ, Caron HN, van Leeuwen FE. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA. 2007;297(24):2705–15.

    Article  CAS  PubMed  Google Scholar 

  • Hudson MM, Mulrooney DA, Bowers DC, Sklar CA, Green DM, Donaldson SS, Oeffinger KC, Neglia JP, Meadows AT, Robison LL. High-risk populations identified in Childhood Cancer Survivor Study investigations: implications for risk-based surveillance. J Clin Oncol. 2009;27(14):2405–14.

    Article  PubMed Central  PubMed  Google Scholar 

  • Hudson MM, Ness KK, Gurney JG, Mulrooney DA, Chemaitilly W, Krull KR, Green DM, Armstrong GT, Nottage KA, Jones KE, Sklar CA, Srivastava DK, Robison LL. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA. 2013;309(22):2371–81.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Institute NC. Common terminology criteria for adverse events, version 4.03. 2010. http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_8.5x11.pdf. Accessed 10 Oct 2014.

  • Kaste SC, Chen G, Fontanesi J, Crom DB, Pratt CB. Orbital development in long-term survivors of retinoblastoma. J Clin Oncol. 1997;15(3):1183–9.

    CAS  PubMed  Google Scholar 

  • Kleinerman RA, Tucker MA, Tarone RE, Abramson DH, Seddon JM, Stovall M, Li FP, Fraumeni Jr JF. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol. 2005;23(10):2272–9.

    Article  PubMed  Google Scholar 

  • Kleinerman RA, Tucker MA, Abramson DH, Seddon JM, Tarone RE, Fraumeni Jr JF. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma. J Natl Cancer Inst. 2007;99(1):24–31.

    Article  PubMed  Google Scholar 

  • Kleinerman RA, Schonfeld SJ, Tucker MA. Sarcomas in hereditary retinoblastoma. Clin Sarcoma Res. 2012a;2(1):15.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Kleinerman RA, Yu CL, Little MP, Li Y, Abramson D, Seddon J, Tucker MA. Variation of second cancer risk by family history of retinoblastoma among long-term survivors. J Clin Oncol. 2012b;30(9):950–7.

    Article  PubMed Central  PubMed  Google Scholar 

  • MacCarthy A, Bayne AM, Draper GJ, Eatock EM, Kroll ME, Stiller CA, Vincent TJ, Hawkins MM, Jenkinson HC, Kingston JE, Neale R, Murphy MF. Non-ocular tumours following retinoblastoma in Great Britain 1951 to 2004. Br J Ophthalmol. 2009;93(9):1159–62.

    Article  CAS  PubMed  Google Scholar 

  • MacCarthy A, Bayne AM, Brownbill PA, Bunch KJ, Diggens NL, Draper GJ, Hawkins MM, Jenkinson HC, Kingston JE, Stiller CA, Vincent TJ, Murphy MF. Second and subsequent tumours among 1927 retinoblastoma patients diagnosed in Britain 1951-2004. Br J Cancer. 2013;108(12):2455–63.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119(7):1050–8.

    Article  CAS  PubMed  Google Scholar 

  • Marees T, Moll AC, Imhof SM, de Boer MR, Ringens PJ, van Leeuwen FE. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up. J Natl Cancer Inst. 2008;100(24):1771–9.

    Article  PubMed  Google Scholar 

  • Mertens AC, Liu Q, Neglia JP, Wasilewski K, Leisenring W, Armstrong GT, Robison LL, Yasui Y. Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2008;100(19):1368–79.

    Article  PubMed Central  PubMed  Google Scholar 

  • Moll AC, Imhof SM, Bouter LM, Tan KE. Second primary tumors in patients with retinoblastoma. A review of the literature. Ophthalmic Genet. 1997;18(1):27–34.

    Article  CAS  PubMed  Google Scholar 

  • Moll AC, Imhof SM, Schouten-Van Meeteren AY, Kuik DJ, Hofman P, Boers M. Second primary tumors in hereditary retinoblastoma: a register-based study, 1945-1997: is there an age effect on radiation-related risk? Ophthalmology. 2001;108(6):1109–14.

    Article  CAS  PubMed  Google Scholar 

  • Nahum MP, Gdal-On M, Kuten A, Herzl G, Horovitz Y, Weyl Ben Arush M. Long-term follow-up of children with retinoblastoma. Pediatr Hematol Oncol. 2001;18(3):173–9.

    Article  CAS  PubMed  Google Scholar 

  • Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, Friedman DL, Marina N, Hobbie W, Kadan-Lottick NS, Schwartz CL, Leisenring W, Robison LL. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355(15):1572–82.

    Article  CAS  PubMed  Google Scholar 

  • Peylan-Ramu N, Bin-Nun A, Skleir-Levy M, Bibas A, Koplewitz B, Anteby I, Pe’er J. Orbital growth retardation in retinoblastoma survivors: work in progress. Med Pediatr Oncol. 2001;37(5):465–70.

    Article  CAS  PubMed  Google Scholar 

  • Robison LL, Mertens AC, Boice JD, Breslow NE, Donaldson SS, Green DM, Li FP, Meadows AT, Mulvihill JJ, Neglia JP, Nesbit ME, Packer RJ, Potter JD, Sklar CA, Smith MA, Stovall M, Strong LC, Yasui Y, Zeltzer LK. Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project. Med Pediatr Oncol. 2002;38(4):229–39.

    Article  PubMed  Google Scholar 

  • Rodjan F, Graaf P, Brisse HJ, Verbeke JI, Sanchez E, Galluzzi P, Goricke S, Maeder P, Aerts I, Dendale R, Desjardins L, de Franscesco S, Bornfeld N, Sauerwein W, Popovic MB, Knol DL, Moll AC, Castelijns JA. Second cranio-facial malignancies in hereditary retinoblastoma survivors previously treated with radiation therapy: clinic and radiologic characteristics and survival outcomes. Eur J Cancer. 2013;49(8):1939–47.

    Article  PubMed  Google Scholar 

  • Rueegg CS, Gianinazzi ME, Rischewski J, Beck Popovic M, von der Weid NX, Michel G, Kuehni CE. Health-related quality of life in survivors of childhood cancer: the role of chronic health problems. J Cancer Surviv. 2013;7(4):511–22.

    Article  PubMed  Google Scholar 

  • van Dijk J, Huisman J, Moll AC, Schouten-van Meeteren AY, Bezemer PD, Ringens PJ, Cohen-Kettenis PT, Imhof SM. Health-related quality of life of child and adolescent retinoblastoma survivors in the Netherlands. Health Qual Life Outcomes. 2007a;5:65.

    Article  PubMed Central  PubMed  Google Scholar 

  • van Dijk J, Imhof SM, Moll AC, Ringens PJ, Cohen-Kettenis PT, Rijmen F, Huisman J. Quality of life of adult retinoblastoma survivors in the Netherlands. Health Qual Life Outcomes. 2007b;5:30.

    Article  PubMed Central  PubMed  Google Scholar 

  • van Dijk J, Oostrom KJ, Imhof SM, Moll AC, Schouten-van Meeteren AY, Bezemer PD, Huisman J. Behavioural functioning of retinoblastoma survivors. Psychooncology. 2009;18(1):87–95.

    Article  PubMed  Google Scholar 

  • van Dijk J, Oostrom KJ, Huisman J, Moll AC, Cohen-Kettenis PT, Ringens PJ, Imhof SM. Restrictions in daily life after retinoblastoma from the perspective of the survivors. Pediatr Blood Cancer. 2010;54(1):110–5.

    Article  PubMed  Google Scholar 

  • Weintraub N, Rot I, Shoshani N, Pe’er J, Weintraub M. Participation in daily activities and quality of life in survivors of retinoblastoma. Pediatr Blood Cancer. 2011;56(4):590–4.

    Article  PubMed  Google Scholar 

  • Willard VW, Qaddoumi I, Chen S, Zhang H, Brennan R, Rodriguez-Galindo C, Wilson MW, Phipps S. Developmental and adaptive functioning in children with retinoblastoma: a longitudinal investigation. J Clin Oncol. 2014;32(25):2788–93.

    Article  PubMed  Google Scholar 

  • Wong FL, Boice Jr JD, Abramson DH, Tarone RE, Kleinerman RA, Stovall M, Goldman MB, Seddon JM, Tarbell N, Fraumeni Jr JF, Li FP. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA. 1997;278(15):1262–7.

    Article  CAS  PubMed  Google Scholar 

  • Wong JR, Morton LM, Tucker MA, Abramson DH, Seddon JM, Sampson JN, Kleinerman RA. Risk of subsequent malignant neoplasms in long-term hereditary retinoblastoma survivors after chemotherapy and radiotherapy. J Clin Oncol. 2014;32(29):3284–90.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Compliance with Ethical Requirements

Danielle Novetsky Friedman declares that she has no conflict of interest.

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all patients for being in the study.

No animal studies were carried out for this article.

Author information

Authors and Affiliations

  1. Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Danielle Novetsky Friedman M.D.

Authors
  1. Danielle Novetsky Friedman M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Danielle Novetsky Friedman M.D. .

Editor information

Editors and Affiliations

  1. Department of Ophthalmic Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA

    Jasmine H. Francis

  2. Department of Ophthalmic Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA

    David H. Abramson

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Friedman, D.N. (2015). Long-Term Follow-Up of Retinoblastoma Survivors. In: Francis, J., Abramson, D. (eds) Recent Advances in Retinoblastoma Treatment. Essentials in Ophthalmology. Springer, Cham. https://doi.org/10.1007/978-3-319-19467-7_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-19467-7_11

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-19466-0

  • Online ISBN: 978-3-319-19467-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation